Open Access5PSQ-084 Safety and effectiveness of switching to infliximab biosimilar in digestive and rheumatological pathology
Author(s) -
J Ramos Rodríguez
Publication year - 2018
Publication title -
section 5: patient safety and quality assurance
Language(s) - English
Resource type - Conference proceedings
DOI - 10.1136/ejhpharm-2018-eahpconf.438
Subject(s) - medicine , infliximab , biosimilar , rheumatoid arthritis , ankylosing spondylitis , retrospective cohort study , adverse effect , rheumatology , vial , ulcerative colitis , inflammatory bowel disease , medical record , adalimumab , disease , surgery , chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom